GLP-1R agonists clinical trial design needs to be improved to reassure drugs’ benefits: GlobalData Read more
Top 20 global biopharma companies report 1.6 per cent per cent market cap growth to $3.67 tn in 2023: GlobalData Read more
Catalent to help Novo Nordisk address production demands for Ozempic and Wegovy: GlobalData Read more
Novo Nordisk Wegovy’s NHS access marks milestone in obesity treatment, but challenges remain: GlobalData Read more